Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Clinical trial NCT04146064 · COMPLETED

Trial details

NCT number: NCT04146064
Sponsor: University Health Network, Toronto
Status: COMPLETED
Study type: OBSERVATIONAL

NSCLC Melanoma Kidney Cancer Urothelial Carcinoma Head and Neck Cancer

Start date: 2020-02-24
Primary completion: 2026-02-09
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.